Dr. Guillermo Torre Amione

Dr. Guillermo Torre Amione is one of Mexico's foremost cardiologists, serving as a senior consultant at Médica Sur — one of Mexico City's premier private hospitals and a recognized leader in international medical tourism. With over 25 years of clinical and research experience, Dr. Torre Amione has dedicated his career to the management of advanced heart failure and cardiac transplantation, establishing himself as a leading figure in this demanding subspecialty in Latin America.

His clinical philosophy centres on evidence-based management of heart failure from early detection through end-stage disease, including guideline-directed medical therapy optimisation, device therapy, and — for appropriately selected patients — cardiac transplantation evaluation and management. He works within Médica Sur's multidisciplinary cardiovascular team, collaborating with cardiac surgeons, electrophysiologists, and critical care specialists.

Beyond advanced heart failure, Dr. Torre Amione maintains a broad cardiology practice encompassing coronary artery disease, valvular disease, and arrhythmia management. He is known for his accessibility to international patients seeking high-quality cardiac care in Mexico at a fraction of US or European costs, and has managed patients from across the Americas and beyond.

He is a Fellow of the American College of Cardiology (FACC) and holds active memberships in both the Mexican Society of Cardiology and the international heart failure community through HFSA and ISHLT.

Dr. Torre Amione completed his medical degree at a leading Mexican medical school before undertaking postgraduate training in internal medicine and cardiology at renowned institutions in Mexico and the United States. He holds a PhD in cardiovascular medicine and completed subspecialty fellowship training in heart failure and cardiac transplantation at a major US academic medical centre, gaining exposure to one of the highest-volume transplant programmes in North America. He is board-certified in internal medicine and cardiovascular disease, and holds the FACC (Fellow of the American College of Cardiology) designation. He has completed advanced training through the Heart Failure Society of America (HFSA) educational programmes and the International Society for Heart and Lung Transplantation (ISHLT) competency framework.

Dr. Torre Amione's core expertise lies in the management of heart failure across all stages, from early-stage HFpEF and HFrEF to end-stage disease requiring advanced therapies. He implements guideline-directed medical therapy (GDMT) optimisation including RAAS inhibitors, beta-blockers, mineralocorticoid receptor antagonists, and SGLT2 inhibitors in eligible patients. For advanced heart failure, he evaluates patients for cardiac resynchronisation therapy (CRT), ICD implantation, and mechanical circulatory support.

He performs diagnostic cardiac catheterisation, coronary angiography, endomyocardial biopsy for cardiomyopathy evaluation, and hemodynamic assessment using right heart catheterisation. For transplant candidates, he coordinates complete pre-transplant evaluation including immunological assessment, psychosocial evaluation, and multidisciplinary listing decisions.

His coronary disease practice includes angioplasty and stenting for obstructive coronary artery disease, and he manages post-ACS patients through comprehensive secondary prevention programmes. He has published research on heart failure outcomes in Latin American populations and inflammatory mechanisms of cardiomyopathy.

Mexico City is an established medical tourism destination, and Médica Sur is one of its most internationally recognised hospitals. Dr. Torre Amione regularly manages international patients — particularly from the United States and Central America — who seek cardiac evaluation, heart failure management, or second opinions on cardiomyopathy at significantly lower cost than US hospitals. He offers video consultations for initial assessment, medical record review, and care planning before patients travel to Mexico City. He consults in Spanish and English. Médica Sur has a dedicated international patient service that assists with coordination, translation, accommodation, and insurance documentation.

Dr. Torre Amione has been recognised by the Mexican Society of Cardiology (SMC) for his contributions to heart failure management in Mexico. He is a Fellow of the American College of Cardiology (FACC) — a distinction reflecting peer-reviewed contributions to cardiovascular medicine. He has received research recognition for his work on inflammatory biomarkers in cardiomyopathy and has presented at HFSA and ACC annual scientific sessions. He is a respected voice in the Latin American cardiology community on advanced heart failure care and cardiac transplantation.